Literature DB >> 1736169

Magnetic resonance demonstration of intracranial CSF flow in children.

R G Curless1, R M Quencer, D A Katz, M Campanioni.   

Abstract

We determined the feasibility and value of studying intracranial CSF flow in children with potential CSF pathway problems using a cardiac gated cine magnetic resonance (MR) format. We studied 15 consecutive patients with a variety of clinical problems that suggested possible CSF pathway problems. The diagnoses included Chiari malformation, Dandy-Walker syndrome, external hydrocephalus, cerebellar tumor, CNS histoplasmosis, and tuberculous meningitis. In addition to documenting the feasibility of the technique in children (7 of 15 were less than 2 years of age), we derived significant new information relative to pathogenesis and/or therapy. The study provides preliminary evidence supporting intracranial CSF flow studies at the time of routine MR imaging of appropriate children.

Entities:  

Mesh:

Year:  1992        PMID: 1736169     DOI: 10.1212/wnl.42.2.377

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Evaluation of CSF flow patterns of posterior fossa cystic malformations using CSF flow MR imaging.

Authors:  Harun Yildiz; Zeynep Yazici; Bahattin Hakyemez; Cuneyt Erdogan; Mufit Parlak
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

2.  Surgical management of Chiari I malformation based on different cerebrospinal fluid flow patterns at the cranial-vertebral junction.

Authors:  Tao Fan; HaiJun Zhao; XinGang Zhao; Cong Liang; YinQian Wang; QiFei Gai
Journal:  Neurosurg Rev       Date:  2017-02-09       Impact factor: 3.042

3.  Correlation of hindbrain CSF flow and outcome after surgical decompression for Chiari I malformation.

Authors:  Matthew J McGirt; April Atiba; Frank J Attenello; Bruce A Wasserman; Ghazala Datoo; Muraya Gathinji; Benjamin Carson; John D Weingart; George I Jallo
Journal:  Childs Nerv Syst       Date:  2008-01-19       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.